Table of Content

1 PET Radiopharmaceuticals Market Overview
1.1 PET Radiopharmaceuticals Product Scope
1.2 PET Radiopharmaceuticals Segment by Type
1.2.1 Global PET Radiopharmaceuticals Sales by Type (2016 & 2021 & 2027)
1.2.2 F-18
1.2.3 Ru-82
1.2.4 Others
1.3 PET Radiopharmaceuticals Segment by Application
1.3.1 Global PET Radiopharmaceuticals Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 PET Radiopharmaceuticals Market Estimates and Forecasts (2016-2027)
1.4.1 Global PET Radiopharmaceuticals Market Size in Value Growth Rate (2016-2027)
1.4.2 Global PET Radiopharmaceuticals Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global PET Radiopharmaceuticals Price Trends (2016-2027)

2 PET Radiopharmaceuticals Estimates and Forecasts by Region
2.1 Global PET Radiopharmaceuticals Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global PET Radiopharmaceuticals Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global PET Radiopharmaceuticals Sales Market Share by Region (2016-2021)
2.2.2 Global PET Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
2.3 Global PET Radiopharmaceuticals Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global PET Radiopharmaceuticals Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global PET Radiopharmaceuticals Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America PET Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.2 Europe PET Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.3 China PET Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.4 Japan PET Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.5 Southeast Asia PET Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.6 India PET Radiopharmaceuticals Estimates and Projections (2016-2027)

3 Global PET Radiopharmaceuticals Competition Landscape by Players
3.1 Global Top PET Radiopharmaceuticals Players by Sales (2016-2021)
3.2 Global Top PET Radiopharmaceuticals Players by Revenue (2016-2021)
3.3 Global PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PET Radiopharmaceuticals as of 2020)
3.4 Global PET Radiopharmaceuticals Average Price by Company (2016-2021)
3.5 Manufacturers PET Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global PET Radiopharmaceuticals Market Size by Type
4.1 Global PET Radiopharmaceuticals Historic Market Review by Type (2016-2021)
4.1.1 Global PET Radiopharmaceuticals Sales Market Share by Type (2016-2021)
4.1.2 Global PET Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
4.1.3 Global PET Radiopharmaceuticals Price by Type (2016-2021)
4.2 Global PET Radiopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global PET Radiopharmaceuticals Sales Forecast by Type (2022-2027)
4.2.2 Global PET Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
4.2.3 Global PET Radiopharmaceuticals Price Forecast by Type (2022-2027)

5 Global PET Radiopharmaceuticals Market Size by Application
5.1 Global PET Radiopharmaceuticals Historic Market Review by Application (2016-2021)
5.1.1 Global PET Radiopharmaceuticals Sales Market Share by Application (2016-2021)
5.1.2 Global PET Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
5.1.3 Global PET Radiopharmaceuticals Price by Application (2016-2021)
5.2 Global PET Radiopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global PET Radiopharmaceuticals Sales Forecast by Application (2022-2027)
5.2.2 Global PET Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
5.2.3 Global PET Radiopharmaceuticals Price Forecast by Application (2022-2027)

6 North America PET Radiopharmaceuticals Market Facts & Figures
6.1 North America PET Radiopharmaceuticals Sales by Company
6.1.1 North America PET Radiopharmaceuticals Sales by Company (2016-2021)
6.1.2 North America PET Radiopharmaceuticals Revenue by Company (2016-2021)
6.2 North America PET Radiopharmaceuticals Sales Breakdown by Type
6.2.1 North America PET Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
6.2.2 North America PET Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
6.3 North America PET Radiopharmaceuticals Sales Breakdown by Application
6.3.1 North America PET Radiopharmaceuticals Sales Breakdown by Application (2016-2021)
6.3.2 North America PET Radiopharmaceuticals Sales Breakdown by Application (2022-2027)

7 Europe PET Radiopharmaceuticals Market Facts & Figures
7.1 Europe PET Radiopharmaceuticals Sales by Company
7.1.1 Europe PET Radiopharmaceuticals Sales by Company (2016-2021)
7.1.2 Europe PET Radiopharmaceuticals Revenue by Company (2016-2021)
7.2 Europe PET Radiopharmaceuticals Sales Breakdown by Type
7.2.1 Europe PET Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
7.2.2 Europe PET Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
7.3 Europe PET Radiopharmaceuticals Sales Breakdown by Application
7.3.1 Europe 127 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 127 Sales Breakdown by Application (2022-2027)

8 China PET Radiopharmaceuticals Market Facts & Figures
8.1 China PET Radiopharmaceuticals Sales by Company
8.1.1 China PET Radiopharmaceuticals Sales by Company (2016-2021)
8.1.2 China PET Radiopharmaceuticals Revenue by Company (2016-2021)
8.2 China PET Radiopharmaceuticals Sales Breakdown by Type
8.2.1 China PET Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
8.2.2 China PET Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
8.3 China PET Radiopharmaceuticals Sales Breakdown by Application
8.3.1 China 153 Sales Breakdown by Application (2016-2021)
8.3.2 China 153 Sales Breakdown by Application (2022-2027)

9 Japan PET Radiopharmaceuticals Market Facts & Figures
9.1 Japan PET Radiopharmaceuticals Sales by Company
9.1.1 Japan PET Radiopharmaceuticals Sales by Company (2016-2021)
9.1.2 Japan PET Radiopharmaceuticals Revenue by Company (2016-2021)
9.2 Japan PET Radiopharmaceuticals Sales Breakdown by Type
9.2.1 Japan PET Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
9.2.2 Japan PET Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
9.3 Japan PET Radiopharmaceuticals Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia PET Radiopharmaceuticals Market Facts & Figures
10.1 Southeast Asia PET Radiopharmaceuticals Sales by Company
10.1.1 Southeast Asia PET Radiopharmaceuticals Sales by Company (2016-2021)
10.1.2 Southeast Asia PET Radiopharmaceuticals Revenue by Company (2016-2021)
10.2 Southeast Asia PET Radiopharmaceuticals Sales Breakdown by Type
10.2.1 Southeast Asia PET Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia PET Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia PET Radiopharmaceuticals Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India PET Radiopharmaceuticals Market Facts & Figures
11.1 India PET Radiopharmaceuticals Sales by Company
11.1.1 India PET Radiopharmaceuticals Sales by Company (2016-2021)
11.1.2 India PET Radiopharmaceuticals Revenue by Company (2016-2021)
11.2 India PET Radiopharmaceuticals Sales Breakdown by Type
11.2.1 India PET Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
11.2.2 India PET Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
11.3 India PET Radiopharmaceuticals Sales Breakdown by Application
11.3.1 India PET Radiopharmaceuticals Sales Breakdown by Application (2016-2021)
11.3.2 India PET Radiopharmaceuticals Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in PET Radiopharmaceuticals Business
12.1 Cardinal Health Inc. (U.S.)
12.1.1 Cardinal Health Inc. (U.S.) Corporation Information
12.1.2 Cardinal Health Inc. (U.S.) Business Overview
12.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Products Offered
12.1.5 Cardinal Health Inc. (U.S.) Recent Development
12.2 Mallinckrodt plc (Ireland)
12.2.1 Mallinckrodt plc (Ireland) Corporation Information
12.2.2 Mallinckrodt plc (Ireland) Business Overview
12.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Products Offered
12.2.5 Mallinckrodt plc (Ireland) Recent Development
12.3 GE Healthcare (U.K.)
12.3.1 GE Healthcare (U.K.) Corporation Information
12.3.2 GE Healthcare (U.K.) Business Overview
12.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Products Offered
12.3.5 GE Healthcare (U.K.) Recent Development
12.4 Lantheus Medical Imaging, Inc. (U.S.)
12.4.1 Lantheus Medical Imaging, Inc. (U.S.) Corporation Information
12.4.2 Lantheus Medical Imaging, Inc. (U.S.) Business Overview
12.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Products Offered
12.4.5 Lantheus Medical Imaging, Inc. (U.S.) Recent Development
12.5 Bayer AG (Germany)
12.5.1 Bayer AG (Germany) Corporation Information
12.5.2 Bayer AG (Germany) Business Overview
12.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Products Offered
12.5.5 Bayer AG (Germany) Recent Development
12.6 Bracco Imaging S.p.A (Italy)
12.6.1 Bracco Imaging S.p.A (Italy) Corporation Information
12.6.2 Bracco Imaging S.p.A (Italy) Business Overview
12.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Products Offered
12.6.5 Bracco Imaging S.p.A (Italy) Recent Development
12.7 Eczacibasi-Monrol Nuclear Products (Turkey)
12.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information
12.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Business Overview
12.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Products Offered
12.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Development
12.8 Nordion, Inc. (Canada)
12.8.1 Nordion, Inc. (Canada) Corporation Information
12.8.2 Nordion, Inc. (Canada) Business Overview
12.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Products Offered
12.8.5 Nordion, Inc. (Canada) Recent Development
12.9 Advanced Accelerator Applications S.A. (France)
12.9.1 Advanced Accelerator Applications S.A. (France) Corporation Information
12.9.2 Advanced Accelerator Applications S.A. (France) Business Overview
12.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Products Offered
12.9.5 Advanced Accelerator Applications S.A. (France) Recent Development
12.10 IBA Molecular Imaging (Belgium)
12.10.1 IBA Molecular Imaging (Belgium) Corporation Information
12.10.2 IBA Molecular Imaging (Belgium) Business Overview
12.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Products Offered
12.10.5 IBA Molecular Imaging (Belgium) Recent Development

13 PET Radiopharmaceuticals Manufacturing Cost Analysis
13.1 PET Radiopharmaceuticals Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of PET Radiopharmaceuticals
13.4 PET Radiopharmaceuticals Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 PET Radiopharmaceuticals Distributors List
14.3 PET Radiopharmaceuticals Customers

15 Market Dynamics
15.1 PET Radiopharmaceuticals Market Trends
15.2 PET Radiopharmaceuticals Drivers
15.3 PET Radiopharmaceuticals Market Challenges
15.4 PET Radiopharmaceuticals Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global PET Radiopharmaceuticals Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global PET Radiopharmaceuticals Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global PET Radiopharmaceuticals Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global PET Radiopharmaceuticals Sales (K Pcs) by Region (2016-2021)
Table 5. Global PET Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 6. Global PET Radiopharmaceuticals Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global PET Radiopharmaceuticals Revenue Share by Region (2016-2021)
Table 8. Global PET Radiopharmaceuticals Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global PET Radiopharmaceuticals Sales Market Share Forecast by Region (2022-2027)
Table 10. Global PET Radiopharmaceuticals Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global PET Radiopharmaceuticals Revenue Share Forecast by Region (2022-2027)
Table 12. Global PET Radiopharmaceuticals Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global PET Radiopharmaceuticals Sales Share by Company (2016-2021)
Table 14. Global PET Radiopharmaceuticals Revenue (US$ Million) by Company (2016-2021)
Table 15. Global PET Radiopharmaceuticals Revenue Share by Company (2016-2021)
Table 16. Global PET Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PET Radiopharmaceuticals as of 2020)
Table 17. Global PET Radiopharmaceuticals Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers PET Radiopharmaceuticals Manufacturing Sites and Area Served
Table 19. Manufacturers PET Radiopharmaceuticals Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global PET Radiopharmaceuticals Sales (K Pcs) by Type (2016-2021)
Table 22. Global PET Radiopharmaceuticals Sales Share by Type (2016-2021)
Table 23. Global PET Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global PET Radiopharmaceuticals Price (USD/Pcs) by Type (2016-2021)
Table 25. Global PET Radiopharmaceuticals Sales Share by Type (2022-2027)
Table 26. Global PET Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global PET Radiopharmaceuticals Revenue Share by Type (2022-2027)
Table 28. Global PET Radiopharmaceuticals Price (USD/Pcs) by Type (2022-2027)
Table 29. Global PET Radiopharmaceuticals Sales (K Pcs) by Application (2016-2021)
Table 30. Global PET Radiopharmaceuticals Sales Share by Application (2016-2021)
Table 31. Global PET Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global PET Radiopharmaceuticals Price (USD/Pcs) by Application (2016-2021)
Table 33. Global PET Radiopharmaceuticals Sales (K Pcs) by Application (2022-2027)
Table 34. Global PET Radiopharmaceuticals Sales Share by Application (2022-2027)
Table 35. Global PET Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global PET Radiopharmaceuticals Revenue Share by Application (2022-2027)
Table 37. Global PET Radiopharmaceuticals Price (USD/Pcs) by Application (2022-2027)
Table 38. North America PET Radiopharmaceuticals Sales (K Pcs) by Company (2016-2021)
Table 39. North America PET Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 40. North America PET Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America PET Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 42. North America PET Radiopharmaceuticals Sales by Type (2016-2021) & (K Pcs)
Table 43. North America PET Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 44. North America PET Radiopharmaceuticals Sales by Type (2022-2027) & (K Pcs)
Table 45. North America PET Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 46. North America PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)
Table 47. North America PET Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 48. North America PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)
Table 49. North America PET Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 50. Europe PET Radiopharmaceuticals Sales (K Pcs) by Company (2016-2021)
Table 51. Europe PET Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 52. Europe PET Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe PET Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 54. Europe PET Radiopharmaceuticals Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe PET Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 56. Europe PET Radiopharmaceuticals Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe PET Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 58. Europe PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe PET Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 60. Europe PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe PET Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 62. China PET Radiopharmaceuticals Sales (K Pcs) by Company (2016-2021)
Table 63. China PET Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 64. China PET Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 65. China PET Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 66. China PET Radiopharmaceuticals Sales by Type (2016-2021) & (K Pcs)
Table 67. China PET Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 68. China PET Radiopharmaceuticals Sales by Type (2022-2027) & (K Pcs)
Table 69. China PET Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 70. China PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)
Table 71. China PET Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 72. China PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)
Table 73. China PET Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 74. Japan PET Radiopharmaceuticals Sales (K Pcs) by Company (2016-2021)
Table 75. Japan PET Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 76. Japan PET Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan PET Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 78. Japan PET Radiopharmaceuticals Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan PET Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 80. Japan PET Radiopharmaceuticals Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan PET Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 82. Japan PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan PET Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 84. Japan PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan PET Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia PET Radiopharmaceuticals Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia PET Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia PET Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia PET Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia PET Radiopharmaceuticals Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia PET Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia PET Radiopharmaceuticals Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia PET Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia PET Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia PET Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 98. India PET Radiopharmaceuticals Sales (K Pcs) by Company (2016-2021)
Table 99. India PET Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 100. India PET Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 101. India PET Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 102. India PET Radiopharmaceuticals Sales by Type (2016-2021) & (K Pcs)
Table 103. India PET Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 104. India PET Radiopharmaceuticals Sales by Type (2022-2027) & (K Pcs)
Table 105. India PET Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 106. India PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)
Table 107. India PET Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 108. India PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)
Table 109. India PET Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 110. Cardinal Health Inc. (U.S.) Corporation Information
Table 111. Cardinal Health Inc. (U.S.) Description and Business Overview
Table 112. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product
Table 114. Cardinal Health Inc. (U.S.) Recent Development
Table 115. Mallinckrodt plc (Ireland) Corporation Information
Table 116. Mallinckrodt plc (Ireland) Description and Business Overview
Table 117. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product
Table 119. Mallinckrodt plc (Ireland) Recent Development
Table 120. GE Healthcare (U.K.) Corporation Information
Table 121. GE Healthcare (U.K.) Description and Business Overview
Table 122. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. GE Healthcare (U.K.) PET Radiopharmaceuticals Product
Table 124. GE Healthcare (U.K.) Recent Development
Table 125. Lantheus Medical Imaging, Inc. (U.S.) Corporation Information
Table 126. Lantheus Medical Imaging, Inc. (U.S.) Description and Business Overview
Table 127. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product
Table 129. Lantheus Medical Imaging, Inc. (U.S.) Recent Development
Table 130. Bayer AG (Germany) Corporation Information
Table 131. Bayer AG (Germany) Description and Business Overview
Table 132. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Bayer AG (Germany) PET Radiopharmaceuticals Product
Table 134. Bayer AG (Germany) Recent Development
Table 135. Bracco Imaging S.p.A (Italy) Corporation Information
Table 136. Bracco Imaging S.p.A (Italy) Description and Business Overview
Table 137. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product
Table 139. Bracco Imaging S.p.A (Italy) Recent Development
Table 140. Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information
Table 141. Eczacibasi-Monrol Nuclear Products (Turkey) Description and Business Overview
Table 142. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product
Table 144. Eczacibasi-Monrol Nuclear Products (Turkey) Recent Development
Table 145. Nordion, Inc. (Canada) Corporation Information
Table 146. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Nordion, Inc. (Canada) Description and Business Overview
Table 148. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product
Table 149. Nordion, Inc. (Canada) Recent Development
Table 150. Advanced Accelerator Applications S.A. (France) Corporation Information
Table 151. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Advanced Accelerator Applications S.A. (France) Description and Business Overview
Table 153. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product
Table 154. Advanced Accelerator Applications S.A. (France) Recent Development
Table 155. IBA Molecular Imaging (Belgium) Corporation Information
Table 156. IBA Molecular Imaging (Belgium) Description and Business Overview
Table 157. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product
Table 159. IBA Molecular Imaging (Belgium) Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. PET Radiopharmaceuticals Distributors List
Table 163. PET Radiopharmaceuticals Customers List
Table 164. PET Radiopharmaceuticals Market Trends
Table 165. PET Radiopharmaceuticals Market Drivers
Table 166. PET Radiopharmaceuticals Market Challenges
Table 167. PET Radiopharmaceuticals Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. PET Radiopharmaceuticals Product Picture
Figure 2. Global PET Radiopharmaceuticals Sales Market Share by Type in 2021 & 2027
Figure 3. F-18 Product Picture
Figure 4. Ru-82 Product Picture
Figure 5. Others Product Picture
Figure 6. Global PET Radiopharmaceuticals Sales Market Share by Application in 2021 & 2027
Figure 7. Oncology Examples
Figure 8. Cardiology Examples
Figure 9. Neurology Examples
Figure 10. Others Examples
Figure 11. Global PET Radiopharmaceuticals Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global PET Radiopharmaceuticals Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global PET Radiopharmaceuticals Sales (K Pcs) Growth Rate (2016-2027)
Figure 14. Global PET Radiopharmaceuticals Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 15. Global PET Radiopharmaceuticals Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global PET Radiopharmaceuticals Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America PET Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America PET Radiopharmaceuticals Sales (K Pcs) Growth Rate (2016-2027)
Figure 19. Europe PET Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe PET Radiopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China PET Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China PET Radiopharmaceuticals Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan PET Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan PET Radiopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia PET Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia PET Radiopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India PET Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India PET Radiopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest PET Radiopharmaceuticals Players Market Share by Revenue in PET Radiopharmaceuticals: 2016 & 2020
Figure 30. PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global PET Radiopharmaceuticals Revenue Share by Type (2016-2021)
Figure 32. Global PET Radiopharmaceuticals Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global PET Radiopharmaceuticals Revenue Share by Application (2016-2021)
Figure 34. Global PET Radiopharmaceuticals Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America PET Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 36. North America PET Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 37. Europe PET Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 38. Europe PET Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 39. China PET Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 40. China PET Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 41. Japan PET Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 42. Japan PET Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 43. Southeast Asia PET Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 44. Southeast Asia PET Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 45. India PET Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 46. India PET Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of PET Radiopharmaceuticals
Figure 49. Manufacturing Process Analysis of PET Radiopharmaceuticals
Figure 50. PET Radiopharmaceuticals Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed